Treatment of Recurrent Acute Lymphoblastic Leukemia

Treatment of recurrent ALL may include:

• combination chemotherapy followed by stem cell transplant
• immunotherapy ( or ) followed by stem cell transplant
• low-dose radiation therapy as palliative care to relieve symptoms and improve quality of life
• targeted therapy with for certain patients
• CAR T-cell therapy ( or ) for certain patients

Some of the treatments being studied in clinical trials for recurrent ALL include stem cell transplant using the patient's stem cells.

To learn more about these treatments, see the Treatment Option Overview.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.